← Leaderboards
Charles Duncan Smart
Vanderbilt University
$140,495
Attributed
$140,495
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $48.1K · FY2020–23$50K$37.5K$25K$12.5K$0
'20
'21
'22
'23
Funding mix
By agency
NIH$140,495 · 1
By mechanism
F30$140,495 · 1
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University
Same institution · by research overlap
- Nancy Joan Brown$32,445,188
- James E Loyd$19,105,238
- John D Imig$12,270,295
- Jorge H Capdevila$6,372,994
- Douglas Eugene Vaughan$19,799,621
Others in their field
Other Emerging Leaders on “Event”
- Valerie Koch · University Corporation For Atmospheric Res$247,762,266
- Peter K Fritschel · California Institute Of Technology$78,820,000
- Ted Ross · University Of Georgia$70,992,558
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Susan M Landau · University Of California Berkeley$47,252,026
- Olwen Hahn · Brigham And Women'S Hospital$36,805,199
Research focus
EventFunctional DisorderCytokineEndotheliumEndothelial DysfunctionDiagnosisAdaptive Immune SystemAngiotensin IiAdultBiological AvailabilityBiological ProductsAutoimmune DiseasesBlood Pressure ReductionAffinityBlr1 GeneAutomobile DrivingCardiovascular DiseasesCardiovascular Risk FactorCardiovascular SystemCd4 Positive T LymphocytesCellsCellular TargetingChemokine ReceptorFuture
Grant awards (4)
Interleukin-21 and endothelial dysfunction in hypertension$48,054
F30 · FY2023 · HL · contact PI
Interleukin-21 and endothelial dysfunction in hypertension$31,463
F30 · FY2022 · HL · contact PI
Interleukin-21 and endothelial dysfunction in hypertension$30,747
F30 · FY2021 · HL · contact PI
Interleukin-21 and endothelial dysfunction in hypertension$30,231
F30 · FY2020 · HL · contact PI